The good news is that the U.S. economy moving into the late-cycle phase, overall growth may slow and signs of an economic slowdown could pop up. Consequently, investors may also turn to defensive sectors that are less economically sensitive, such as health care.

The Affordable Care Act has helped millions of Americans receive healthcare coverage, with the uninsured rate now at a seven-year low, bolstering the outlook for healthcare services and sector-related exchange traded funds.

Related: A Healthcare ETF That’s Really Healthy

PJP “trades at about 3.35 times book value and the return on equity is respectable at 11.79%. So if the devil on one shoulder is urging you to jump in, it’s better to listen to the angel on the other, suggesting a little patience,” adds Seeking Alpha.

Other pharmaceuticals ETFs include the SPDR Pharmaceuticals ETF (NYSEArca: XPH), iShares U.S. Pharmaceuticals ETF (NYSEArca: IHE) and the VanEck Vectors Pharmaceutical ETF (NYSEArca: PPH).

Visit for more ETF news, strategy and commentary.

PowerShares Dynamic Pharmaceuticals Portfolio